ATE221784T1 - Arzneimittel zur heilung von thrombozytopenie - Google Patents

Arzneimittel zur heilung von thrombozytopenie

Info

Publication number
ATE221784T1
ATE221784T1 AT96907755T AT96907755T ATE221784T1 AT E221784 T1 ATE221784 T1 AT E221784T1 AT 96907755 T AT96907755 T AT 96907755T AT 96907755 T AT96907755 T AT 96907755T AT E221784 T1 ATE221784 T1 AT E221784T1
Authority
AT
Austria
Prior art keywords
thrombocytopenia
cure
medicine
thrombocyte
thrombocytes
Prior art date
Application number
AT96907755T
Other languages
English (en)
Inventor
Yasushi Shimonaka
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE221784T1 publication Critical patent/ATE221784T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5443—IL-15
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96907755T 1995-04-02 1996-04-02 Arzneimittel zur heilung von thrombozytopenie ATE221784T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11221895 1995-04-02
PCT/JP1996/000898 WO1996031230A1 (en) 1995-04-02 1996-04-02 Medicinal composition for curing thrombocytopenia

Publications (1)

Publication Number Publication Date
ATE221784T1 true ATE221784T1 (de) 2002-08-15

Family

ID=14581220

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96907755T ATE221784T1 (de) 1995-04-02 1996-04-02 Arzneimittel zur heilung von thrombozytopenie

Country Status (7)

Country Link
US (1) US6258352B1 (de)
EP (1) EP0823257B1 (de)
AT (1) ATE221784T1 (de)
AU (1) AU700250B2 (de)
CA (1) CA2217122C (de)
DE (1) DE69622854T2 (de)
WO (1) WO1996031230A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE221784T1 (de) 1995-04-02 2002-08-15 Chugai Pharmaceutical Co Ltd Arzneimittel zur heilung von thrombozytopenie
CN101073667B (zh) * 1997-10-14 2013-11-06 中外制药株式会社 淋巴细胞肿瘤抗体的增强剂
AU784460B2 (en) * 1999-08-23 2006-04-06 Chugai Seiyaku Kabushiki Kaisha HM1.24 antigen expression potentiators
EP1364657B1 (de) * 2001-02-07 2016-12-28 Chugai Seiyaku Kabushiki Kaisha Mittel gegen myelozytenleukämie
US7247304B2 (en) * 2001-08-23 2007-07-24 Genmab A/S Methods of treating using anti-IL-15 antibodies
US7329405B2 (en) * 2001-08-23 2008-02-12 Genmab A/S Human antibodies specific for interleukin 15 (IL-15)
PL217752B1 (pl) * 2001-08-23 2014-08-29 Genmab As Izolowane ludzkie przeciwciało monoklonalne wobec IL-15 lub jego fragment wiążący antygen i związane z nimi hybrydoma, kompozycja farmaceutyczna oraz zastosowania medyczne
WO2005023289A1 (ja) * 2003-09-08 2005-03-17 Intellectual Property Consulting Incorporated 慢性ｃ型肝炎を治療するための医薬組成物
EP3055419B1 (de) 2013-10-13 2021-01-20 Nova Southeastern University Therapeutische anwendung von il-15 zur modulation der funktion von nk-zellen in patienten mit golfkriegssyndrom
CN104212808B (zh) * 2014-09-05 2017-03-08 中国科学院广州生物医药与健康研究院 重组人白介素15长肽段及其生产方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552303A (en) * 1993-03-08 1996-09-03 Immunex Corporation DNA encoding epithelium-derived T-cell factor
US5747024A (en) * 1993-03-08 1998-05-05 Immunex Corporation Vaccine adjuvant comprising interleukin-15
ATE196315T1 (de) * 1994-04-06 2000-09-15 Immunex Corp Interleukin-15
ATE221784T1 (de) 1995-04-02 2002-08-15 Chugai Pharmaceutical Co Ltd Arzneimittel zur heilung von thrombozytopenie

Also Published As

Publication number Publication date
US6258352B1 (en) 2001-07-10
CA2217122A1 (en) 1996-10-10
AU5123696A (en) 1996-10-23
EP0823257A1 (de) 1998-02-11
EP0823257B1 (de) 2002-08-07
WO1996031230A1 (en) 1996-10-10
CA2217122C (en) 2004-10-26
AU700250B2 (en) 1998-12-24
EP0823257A4 (de) 1998-04-01
DE69622854D1 (de) 2002-09-12
DE69622854T2 (de) 2003-04-10

Similar Documents

Publication Publication Date Title
FR2698875B1 (fr) Système silicone modulateur d'adhérence et son utilisation pour la préparation de compositions antiadhérentes durcissables.
AU7362496A (en) Dimer-selective rxr modulators and methods for their use
ID30373A (id) PARAHERKUAMIDA ANTIPARASIT (Pecahan P-962086)
ATE221784T1 (de) Arzneimittel zur heilung von thrombozytopenie
DE69633194D1 (de) Kombination pdgf, kgf, igf und igfbp zur wundheilung
EE9800080A (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
DE69521521D1 (de) Mono- oder polyfunktionelle konjugate von polylysine
DE59409604D1 (de) Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12
DE69808620D1 (de) Universell verwendbares bluttplasma
DE69325393D1 (de) Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen
EE05276B1 (et) Kasvaja nekroosifaktori sugulasligand
ES8106720A1 (es) Un procedimiento para la preparacion de diariltiofenos.
DK0587087T3 (da) Substituerede cyclohexan-derivater til behandling af sygdomme
DK0386700T3 (da) Anvendelse af inhalerede "loop"-diuretika til behandling af allergenfremkaldte, nasale reaktioner
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
ATE233812T1 (de) Peptide mit pronociceptiveigenschaften
DE69327693D1 (de) Interferon-Alpha/Beta bindendes Protein, seine Herstellung und seine enthaltende pharmazeutische Zusammensetzungen
DE69626050D1 (de) Pharmazeutische zusammensetzung enthaltend interferon-gamma stimulatoren
AU7004887A (en) Novel phenylureas
DK0655251T3 (da) Farmaceutisk præparat til forebyggelse eller behandling af knoglebrud
AU1506692A (en) Pharmaceutical compositions
AU7390891A (en) Anti-oncostatin m monoclonal antibodies
DE69005241D1 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen.
ATE315583T1 (de) Analoge des thymosin alpha 1

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties